Standardized preoperative DOAC Interruption Achieves Low Anticoagulant Levels, provides safety from blood loss: JAMA

Published On 2026-02-20 15:00 GMT | Update On 2026-02-20 15:00 GMT

Researchers have found in a cohort study that a standardized preoperative interruption protocol generally resulted in direct oral anticoagulant (DOAC) levels below 30 ng/mL in most patients undergoing surgery. However, patients receiving apixaban were more likely to have residual DOAC levels of 30 ng/mL or higher compared with other agents. Importantly, preoperative direct oral anticoagulant levels were not associated with increased intraoperative blood loss, supporting the overall safety of the current interruption protocol.

Before elective surgery, direct oral anticoagulants (DOACs) are discontinued following a standardized protocol. However, this could result in insufficient lowering of direct oral anticoagulant levels that could increase bleeding risk. A study was done to estimate the proportion of patients with elevated direct oral anticoagulant levels at the time of elective surgery, evaluate factors associated with

direct oral anticoagulant levels, and examine associated blood loss. This cohort study (direct oral anticoagulant Level Prior to Incision [DALI]) assessed adult patients prescribed a direct oral anticoagulant (apixaban, dabigatran, or rivaroxaban) for any indication and at any dose, undergoing an elective procedure requiring direct oral anticoagulant interruption between May 27, 2018, and February 25, 2024, at 2 Dutch hospitals. Blood was drawn immediately before surgery to determine

direct oral anticoagulant levels (by liquid chromatography–mass spectrometry). Proportions of preoperative direct oral anticoagulant levels of 30 ng/mL or higher and their 95% CIs were estimated, stratified by direct oral anticoagulant type and surgical bleeding risk. Factors associated with direct oral anticoagulant levels were identified through multivariable linear regression. Surgical blood loss and 30-day postoperative complications were described according to

direct oral anticoagulant concentrations. Results The study was terminated after including 257 patients (100 receiving apixaban, 100 receiving rivaroxaban, and 57 receiving dabigatran due to the slow inclusion rate of those receiving dabigatran; median [IQR] age, 72 [66-78] years; 173 male [67%]); 212 patients (82%) underwent a high bleeding-risk operation. Preprocedural direct oral anticoagulant

levels were 30 ng/mL or higher in 7.6% (95% CI, 4.9%-11.6%) of patients. Dabigatran and rivaroxaban had similar proportions, whereas 13.1% (95% CI, 7.8%-21.2%) of patients treated with apixaban had levels of 30 ng/mL or higher. Treatment with apixaban, decreased kidney function, and a shorter interruption time were associated with higher levels. Surgical blood loss (median [range], 0 [0-4250] mL) was not associated with

direct oral anticoagulant levels. Twelve patients (4.7%; 95% CI, 2.7%-8.0%), who all had direct oral anticoagulants levels less than 30 ng/mL, experienced major bleeding.

In this cohort study, most patients following the current protocol had direct oral anticoagulant levels less than 30 ng/mL, although the proportion of patients with elevated levels was higher for apixaban. Preoperative

direct oral anticoagulant levels were not associated with blood loss during surgery.

Reference:

Camilleri E, Shahbabai P, Rad M, et al. Direct Oral Anticoagulant Levels at Time of Elective Surgery. JAMA Netw Open. 2026;9(2):e2555875. doi:10.1001/jamanetworkopen.2025.55875

Keywords:

Camilleri E, Shahbabai P, Rad M, Standardised, preoperative, DOAC, Interruption, Achieves, Low, Anticoagulant Levels, provides, safety, blood loss, JAMA, direct oral anticoagulant

Article Source : JAMA

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Shravani Dali

Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Standardized preoperative DOAC Interruption Achieves Low Anticoagulant Levels, provides safety from blood loss: JAMA

Similar News

Surgical innovation cuts ovarian cancer risk by nearly 80%: Study

Older patients may have increased risk of complications and mortality after Thyroidectomy, suggests study

Ketamine/Esketamine May Reduce Postoperative Pain and Opioid Use After Laparoscopic Cholecystectomy: Study

Circulating Fibrocytes Promising as Diagnostic Marker for Acute Appendicitis: Study Shows

Early Trismus Therapy Shows Lasting Benefits After Facial Nerve Reconstruction: Study

First-of-its-kind probe monitors fetal health in utero during surgery: Study

Gaps Between Surgeon Expectations and Real-World Effects of Intraoperative Artificial Intelligence (AI) Intervention-JAMA Surgery Findings